The supraspinal network in the control of erection

Expert Opinion on Therapeutic Targets

Volumn 9, Issue 5, 2005, Pages 941-954

  Temel, Yasin ^a   Hafizi, Sepehr ^b   Beuls, Emile ^a   Visser Vanderwalle, Veerle ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Erectile dysfunction (ED); Erection; Modulation; Neuromediator; Spinal; Stimulation; Supraspinal

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID; ANDROGEN; APOMORPHINE; BACLOFEN; BROMOCRIPTINE; CLOZAPINE; DIZOCILPINE; DOMPERIDONE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; GLYCERYL TRINITRATE; HALOPERIDOL; LEVODOPA; LISURIDE; MORPHINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER; NITRIC OXIDE; OXYTOCIN; PLACEBO; QUINELORANE; SEROTONIN; SILDENAFIL; SUMANIROLE; UNINDEXED DRUG;

AMYGDALOID NUCLEUS; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CINGULATE GYRUS; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; FRONTAL LOBE; HUMAN; HYPOTHALAMUS; IMPOTENCE; MESENCEPHALON; NAUSEA; NERVOUS SYSTEM FUNCTION; NONHUMAN; PARKINSON DISEASE; PENIS ERECTION; PHARMACOLOGICAL BLOCKING; REVIEW; SCHIZOPHRENIA; SPINAL CORD; THALAMUS NUCLEUS;

ANIMALS; BRAIN; ERECTILE DYSFUNCTION; HUMANS; IMPOTENCE; MALE; NEUROTRANSMITTER AGENTS; PENILE ERECTION;

EID: 27144520978     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.9.5.941     Document Type: Review

References (153)

1. KANDEEL FR, KOUSSA VK, SWERDLOFF RS: Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr. Rev. (2001) 22(3):342-388.
2. LUE TF: Erectile dysfunction. N. Engl. J. Med. (2000) 342(24):1802-1813.
3. STEERS WD: Neural pathways and central sites involved in penile erection: neuroanatomy and clinical implications. Neurosci. Biobehav. Rev. (2000) 24(5):507-516.
4. ROSEN RC, SACHS BD: Central mechanisms in the control of penile erection: current theory and research. Neurosci. Biobehav. Rev. (2000) 24(5):503-505.
5. SHABSIGH R, ANASTASIADIS AG: Erectile dysfunction. Ann. Rev. Med. (2003) 54:153-168.
6. GIULIANO F, RAMPIN O: Central neural regulation of penile erection. Neurosci. Biobehav. Rev. (2000) 24(5):517-533.
7. MCKENNA KE: Some proposals regarding the organization of the central nervous system control of penile erection. Neurosci. Biobehav. Rev. (2000) 24(5):535-540.
8. RAMPIN O, GIULIANO F: Brain control of penile erection. World J. Urol. (2001) 19(1):1-8.
9. TEMEL Y, VISSER-VANDEWALLE V, ACKERMANS L, BEULS EA: Thalamus and penile erection. Int. J. Impot. Res. (2004) 16(6):505-511.
10. KUTHE A: Phosphodiesterase 5 inhibitors in male sexual dysfunction. Curr. Opin. Urol. (2003) 13(5):405-410.
11. MCKENNA KE: Central control of penile erection. Int. J. Impot. Res. (1998) 10(Suppl. 1):S25-S34.
12. BEACH FA: Sexual attractivity, proceptivity, and receptivity in female mammals. Horm. Behav. (1976) 7(1):105-138.
13. ARGIOLAS A: Oxytocin stimulation of penile erection. Pharmacology, site, and mechanism of action. Ann. NY Acad. Sci. (1992) 652:194-203.
14. MONTORSI F: Tolerability and safety of apomorphine SL (Ixense (TM)). Int. J. Impot. Res. (2003) 15(Suppl. 2):S7-S9.
15. MONTORSI F, SALONIA A, DEHO F et al.: Pharmacological management of erectile dysfunction. BJU Int. (2003) 91(5):446-454.
16. HSIEH GC, HOLLINGSWORTH PR, MARTINO B et al.: Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine. J. Pharmacol. Exp. Ther. (2004) 308(1):330-338.
17. TEMEL Y, VAN LANKVELD JJ, BOON P et al.: Deep brain stimulation of the thalamus can influence penile erection. Int. J. Impot. Res. (2004) 16(1):91-94.
18. MACLEAN PD, PLOOG DW: Cerebral presentation of penile erection. J. Neurophysiol. (1962) 25(1):29-55.
19. MAHL GF, ROTHENBERG A, DELGADO JM, HAMLIN H: Psychological responses in the human to intracerebral electrical stimulation. Psychosom. Med. (1964) 26:337-368.
20. DELGADO JR, HAMLIN H, HIGGINS JW, MAHL GF: Behavioral changes during intracerebral electrical stimulation. AMA Arch. Neurol. Psychiatry (1956) 76(4):399-419.
21. DELGADO JM, ROSVOLD HE, LOONEY E: Evoking conditioned fear by electrical stimulation of subcortical structures in the monkey brain. J. Comp. Physiol. Pychol. (1956) 49(4):373-380.
22. PENFIELD W: The electrode, the brain and the mind. Z. Neurol. (1972) 201(4):297-309.
23. DUA S, MACLEAN PD: Localization for penile erection in medial frontal lobe. Am. J. Physiol. (1964) 207:1425-1434.
24. PARK K, SEO JJ, KANG HK et al.: A new potential of blood oxygenation level dependent (BOLD) functional MRI for evaluating cerebral centers of penile erection. Int. J. Impot. Res. (2001) 13(2):73-81.
25. ROBINSON BW, MISHKIN M: Penile erection evoked from forebrain structures in Macaca mulatta. Arch. Neurol. (1968) 19(2):184-198.
26. ARNOW BA, DESMOND JE, BANNER LL et al.: Brain activation and sexual arousal in healthy, heterosexual males. Brain (2002) 125(Pt 5):1014-1023.
27. MARTIN JH: Neuroanatomy (Ed.) Appleton & Lange, Stamford, CT, (1996):447-475.
28. VALCOURT RJ, SACHS BD: Penile reflexes and copulatory behavior in male rats following lesions in the bed nucleus of the stria terminalis. Brain Res. Bull. (1979) 4(1):131-133.
29. LIU YC, SALAMONE JD, SACHS BD: Lesions in medial preoptic area and bed nucleus of stria terminalis: differential effects on copulatory behavior and noncontact erection in male rats. J. Neurosci. (1997) 17(13):5245-5253.
30. BIALY M, SACHS BD: Androgen implants in medial amygdala briefly maintain noncontact erection in castrated male rats. Horm. Behav. (2002) 42(3):345-355.
31. MACLEAN PD, DENNISTON RH, DUA S: Further studies on cerebral representation of penile erection: caudal thalamus, midbrain, and pons. J. Neurophysiol. (1963) 26(2):273-293.
32. SAPOLSKY RM, EICHENBAUM H: Thalamocortical mechanisms in odor-guided behavior. II. Effects of lesions of the mediodorsal thalamic nucleus and frontal cortex on odor preferences and sexual behavior in the hamster. Brain Behav. Evol. (1980) 17(4):276-290.
33. VANDEWALLE V, VAN DER LINDEN C, GROENEWEGEN HJ, CAEMAERT J: Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet (1999) 353(9154):724.
34. VISSER-VANDEWALLE V, TEMEL Y, BOON P et al.: Chronic bilateral thalamic stimulation, a new therapeutic approach in intractable Tourette syndrome. A report of three cases. J. Neurosurg. (2003) 99(6):1094-100
35. MONAGHAN EP, ARJOMAND J, BREEDLOVE SM: Brain lesions affect penile reflexes. Horm. Behav. (1993) 27(1):122-131.
36. KIPPIN TE, SOTIROPOULOS V, BADIH J, PFAUS JG: Opposing roles of the nucleus accumbens and anterior lateral hypothalamic area in the control of sexual behaviour in the male rat. Eur. J. Neurosci. (2004) 19(3):698-704.
37. GIULIANO F, BERNABE J, BROWN K et al.: Erectile response to hypothalamic stimulation in rats: role of peripheral nerves. Am. J. Physiol. (1997) 273(6 Pt 2):R1990-R1997.
38. MAILLARD-GUTEKUNST CA, EDWARDS DA: Preoptic and subthalamic connections with the caudal brainstem are important for copulation in the male rat. Behav. Neurosci. (1994) 108(4):758-766.
39. CLARO F, SEGOVIA S, GUILAMON A, DEL ABRIL A: Lesions in the medial posterior region of the BST impair sexual behavior in sexually experienced and inexperienced male rats. Brain Res. Bull. (1995) 36(1):1-10.
40. DIECKMANN G, HASSLER R: Unilateral hypothalamotomy in sexual delinquents. Report on six cases. Confin. Neurol. (1975) 37(1-3):177-186.
41. CREUTZFELDT OD: Neurobiological basis of hypothalamotomy in sexual deviation (author's transl). Nervenarzt (1979) 50(11):671-681.
42. RIEBER I, SIGUSCH V: Psychosurgery on sex offenders and sexual 'deviants' in West Germany. Arch. Sex. Behav. (1979) 8(6):523-527.
43. IMAGAWA A, KAWANISHI Y, KAGAWA S, KUROKAWA K: Testing of brain-stem function in 134 patients complaining of impotence. Hinyokika Kiyo (1987) 33(11):1818-1822.
44. GUYTON AC, HALL JE: Somatic Sensations: the tactile and position senses. In: Textbook of medical physiology. Guyton AC et al. (eds) W. B. Saunders, Philadelphia (1996) 595-607.
45. ALEXANDER GE, CRUTCHER MD, DELONG MR: Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog. Brain Res. (1990) 85:119-146.
46. ANDERSSON KE, HEDLUND P: New directions for erectile dysfunction therapies. Int. J. Impot. Res. (2002) 14(Suppl. 1):S82-S92.
47. HEATON JP: Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine. Neurosci. Biobehav. Rev. (2000) 24(5):561-569.
48. ANDERSSON KE: Pharmacology of penile erection. Pharmacol. Rev. (2001) 53(3):417-450.
49. SACHS BD, AKASOFU K, MCELDOWNEY SS: Effects of copulation on apomorphine-induced erection in rats. Pharmacol. Biochem. Bebav. (1994) 48(2):423-428.
50. BITRAN D, HULL EM: Pharmacological analysis of male rat sexual behavior. Neurosci. Biobehav. Rev. (1987) 11(4):365-389.
51. POMERANTZ SM: Apomorphine facilitates male sexual behavior of rhesus monkeys. Pharmacol. Biochem. Behav. (1990) 35(3):659-664.
52. HEATON JP, VARRIN SJ, MORALES A: The characterization of a bio-assay of erectile function in a rat model. J. Urol. (1991) 145(5):1099-1102.
53. RAMPIN O, JEROME N, SUAUDEAU C: Proerectile effects of apomorphine in mice. Life Sci. (2003) 72(21):2329-2336.
54. MATSUOKA N, MAEDA N, YAMAZAKI M, YAMAGUCHI I: Brain somatostatin depletion by cysteamine attenuates the penile erection induced by serotonergic and dopaminergic, but not by cholinergic, activation in rats. Brain Res. (1996) 729(1):132-136.
55. PEHEK EA, THOMPSON JT, EATON RC, BAZZETT TJ, HULL EM: Apomorphine and haloperidol, but not domperidone, affect penile reflexes in rats. Pharmacol. Biochem. Behav. (1988) 31(1):201-208.
56. D'AQUILA PS, PEANA AT, PANIN F et al.: Reversal of antidepressant-induced dopaminergic behavioural supersensitivity after long-term chronic imipramine withdrawal. Eur. J. Pharmacol. (2003) 458(1-2):129-134.
57. CHEN KK, CHAN JY, CHANG LS: Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat. J. Urol. (1999) 162(1):237-242.
58. MELIS MR, SUCCU S, ARGIOLAS A: Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning. Eur. J. Neurosci. (1996) 8(10):2056-2063.
59. FERRARI F, OTTANI A, GIULIANI D: Influence of sildenafil on central dopamine-mediated behaviour in male rats. Life Sci. (2002) 70(13):1501-1508.
60. DOHERTY PC, WISLER PA: Stimulatory effects of quinelorane on yawning and penile erection in the rat. Life Sci. (1994) 54(7):507-514.
61. BAGGIO G, FERRARI F: The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats. Pychopharmacology (Berl) (1983) 80(1):38-42.
62. FERRARI F, GIULIANI D: Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats. Eur. J. Pharmacol. (1993) 250(1):51-57.
63. FERRARI F, GIULIANI D: Behavioural effects induced in rats and chicks by D2 dopamine agonists. Physiol. Behav. (1993) 54(4):695-700.
64. FERRARI F, GIULIANI D: Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats. Neuropharmacology (1997) 36(6):769-777.
65. GIULIANI D, FERRARI F: Differential behavioral response to dopamine D2 agonists by sexually naive, sexually active, and sexually inactive male rats. Behav. Neurosci. (1996) 110(4):802-808.
66. FERRARI F, MANGIAFICO V, TARTONI P, TAMPIERI A: Imidazole and yohimbine antagonize hypomotility, penile erection, stretching and yawning induced in rats by BHT 920, a selective dopamine autoreceptor agonist. Pharmacol. Res. Commun. (1988) 20(9):827-837.
67. FERRARI F, MANGIAFICO V: Effect of isolation on dopaminergic agonist-induced penile erections and stretching and yawning in male rats. Behav. Brain Res. (1988) 28(3):309-313.
68. BAZZETT TJ, EATON RC, THOMPSON JT et al.: Dose dependent D2 effects on genital reflexes after MPOA injections of quinelorane and apomorphine. Life Sci. (1991) 48(24):2309-2315.
69. POMERANTZ SM: Quinelorane (LY163502), a D2 dopamine receptor agonist, acts centrally to facilitate penile erections of male rhesus monkeys. Pharmacol. Biochem. Behav. (1991) 39(1):123-128.
70. EATON RC, MARKOWSKI VP, LUMLEY LA et al.: D2 receptors in the paraventricular nucleus regulate genital responses and copulation in male rats. Pharmacol. Biochem. Behav. (1991) 39(1):177-181.
71. FERRARI F, GIULIANI D: Behavioural effects of the dopamine D3 receptor agonist 7-OH-DPAT in rats. Pharmacol. Res. (1995) 32(1-2):63-68.
72. BRIONI JD, MORELAND RB, COWART M et al.: Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. Proc. Natl. Acad. Sci. USA (2004) 101(17):6758-6763.
73. COWART M, LATSHAW SP, BHATIA P et al.: Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. J. Med. Chem. (2004) 47(15):3853-3864.
74. MELIS MR, SUCCU S, MASCIA MS, ARGIOLAS A: PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male rats. Neurosci. Lett. (2005) 379(1):59-62.
75. MELIS MR, ARGIOLAS A, GESSA GL: Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system. Eur. J. Pharmacol. (1989) 164(3):565-570.
76. ARGIOLAS A, MELIS MR: The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol. Behav. (2004) 83(2):309-317.
77. DU J, LORRAIN DS, HULL EM: Castration decreases extracellular, but increases intracellular, dopamine in medial preoptic area of male rats. Brain Res. (1998) 782(1-2):11-17.
78. HULL EM, MUSCHAMP JW, SATO S: Dopamine and serotonin: influences on male sexual behavior. Physiol. Behav. (2004) 83(2):291-307.
79. DOMINGUEZ JM, MUSCHAMP JW, SCHMICH JM, HULL EM: Nitric oxide mediates glutamate-evoked dopamine release in the medial preoptic area. Neuroscience (2004) 125(1):203-210.
80. DANJOU P, ALEXANDRE L, WAROT D, LACOMBLEZ L, PUECH AJ: Assessment of erectogenic properties of apomorphine and yohimbine in man. Br. J. Clin. Pharmacol. (1988) 26(6):733-739.
81. LAL S, ACKMAN D, THAVUNDAYIL JX, KIELY ME, ETIENNE P: Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry (1984) 8(4-6):695-699.
82. LAL S, TESFAYE Y, THAVUNDAYIL JX et al.: Apomorphine: clinical studies on erectile impotence and yawning. Prog. Neuropsychopharmacol. Biol. Psychiatry (1989) 13(3-4):329-339.
83. HEATON JP, MORALES A, ADAMS MA, JOHNSTON B, EL-RASHIDY R: Recovery of erectile function by the oral administration of apomorphine. Urology (1995) 45(2):200-206.
84. PADMA-NATHAN H: A new era in the treatment of erectile dysfunction. Am. J. Cardiol. (1999) 84(5B):18N-23N.
85. DULA E, KEATING W, SIAMI PF et al.: Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group. Urology (2000) 56(1):130-135.
86. DULA E, BUKOFZER S, PERDOK R, GEORGE M: Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur. Urol. (2001) 39(5):558-553; discussion 564.
87. GIULIANO F, RAMPIN O: Neural control of erection. Physiol. Behav. (2004) 83(2):189-201.
88. BOWERS MB, JR., VAN WOERT M, DAVIS L: Sexual behavior during L-dopa treatment for Parkinsonism. Am. J. Psychiatry (1971) 127(12):1691-1693.
89. BROWN E, BROWN GM, KOFMAN O, QUARRINGTON B: Sexual function and affect in parkinsonian men treated with L-dopa. Am. J. Psychiatry (1978) 135(12):1552-1555.
90. COURTY E, DURIF F, ZENUT M, COURTY P, LAVARENNE J: Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease. Clin. Neuropharmacol. (1997) 20(2):140-147.
91. O'SULLIVAN JD, HUGHES AJ: Apomorphine-induced penile erections in Parkinson's disease. Mov. Disord. (1998) 13(3):536-539.
92. UITTI RJ, TANNER CM, RAJPUT AH et al.: Hypersexuality with antiparkinsonian therapy. Clin. Neuropharmacol. (1989) 12(5):375-383.
93. VALEVSKI A, MODAI I, ZBARSKI E, ZEMISHLANY Z, WEIZMAN A: Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients. Clin. Neuropharmacol. (1998) 21(6):355-357.
94. SCHLATTER EK, LAL S: Treatment of alcoholism with Dent's oral apomorphine method. Q J. Stud. Alcohol (1972) 33(2):430-436.
95. MULHALL JP: Sublingual apomorphine for the treatment of erectile dysfunction. Expert Opin. Investig. Drugs (2002) 11(2):295-302.
96. LAL S, LARYEA E, THAVUNDAYIL JX et al.: Apomorphine-induced penile tumescence in impotent patients-preliminary findings. Prog. Neuropsychopharmacol. Biol. Psychiatry (1987) 11(2-3):235-242.
97. LAL S, KIELY ME, THAVUNDAYIL JX et al.: Effect of bromocriptine in patients with apomorphine-responsive erectile impotence: an open study. J. Psychiatry Neurosci. (1991) 16(5):262-266.
98. COOPER AJ: Bromocriptine in impotence. Lancet (1977) 2(8037):567.
99. MCINTOSH TK, BARFIELD RJ: Brain monoaminergic control of male reproductive behavior. I. Serotonin and the post-ejaculatory refractory period. Behav. Brain Res. (1984) 12(3):255-265.
100. KONDO Y, YAMANOUCHI K, ARAI Y: P-chlorophenylalanine facilitates copulatory behavior in septal lesioned but not in preoptic lesioned male rats. J. Neuroendocrinol. (1993) 5(6):629-633.
101. AHLENIUS S, LARSSON K, SVENSSON L et al.: Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol. Biochem. Behav. (1981) 15(5):785-792.
102. SVENSSON L, HANSEN S: Spinal monoaminergic modulation of masculine copulatory behavior in the rat. Brain Res. (1984) 302(2):315-321.
103. SZELE FG, MURPHY DL, GARRICK NA: Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates. Life Sci. (1988) 43(16):1297-1303.
104. HAYES ES, ADAIKAN PG: Metachlorophenylpiperazine (m-CPP) induced intracavernous pressure responses in anaesthetized rats. Int. J. Impot. Res. (2002) 14(4):287-294.
105. KIMURA Y, HATANAKA K, NAITOU Y et al.: Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist. Eur. J. Pharmacol. (2004) 483(1)37-43.
106. CHAGRAOUI A, PROTAIS P, FILLOUX T, MOCAER E: Agomelatine (S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats. Psychopharmacology (Berl) (2003) 170(1):17-22.
107. MILLAN MJ, GOBERT A, LEJEUNE F et al.: The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J. Pharmacol. Exp. Ther. (2003) 306(3):954-964.
108. AIZENBERG D, GUR S, ZEMISHLANY Z et al.: Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin. Neuropharmacol. (1997) 20(3):210-214.
109. BAGDY G, KALOGERAS KT, SZEMEREDI K: Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations. Eur. J. Pharmacol. (1992) 229(1):9-14.
110. BERENDSEN HH, BROEKKAMP CL: Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants. Psychopharmacology (Berl) (1991) 105(2):219-224.
111. MILLAN MJ, PEGLION JL, LAVIELLE G, PERRIN-MONNEYRON S: 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Eur. J. Pharmacol. (1997) 325(1):9-12.
112. POMERANTZ SM, HEPNER BC, WERTZ JM: Serotonergic influences on male sexual behavior of rhesus monkeys: effects of serotonin agonists. Psychopharmacology (Berl) (1993) 111(1):47-54.
113. ALOI JA, INSEL TR, MUELLER EA, MURPHY DL: Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sci. (1984) 34(14):1325-1331.
114. BROTTO LA, GORZALKA BB: Melatonin enhances sexual behavior in the male rat. Physiol. Behav. (2000) 68(4):483-486.
115. GOLDSTEIN I, LUE TF, PADMA-NATHAN H et al.: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N. Engl. J. Med. (1998) 338(20):1397-1404.
116. TODA N, AYAJIKI K, OKAMURA T: Nitric oxide and penile erectile function. Pharmacol. Ther. (2005) 106(2):233-266.
117. MELIS MR, STANCAMPIANO R, ARGIOLAS A: Nitric oxide synthase inhibitors prevent N-methyl-D-aspartic acid-induced penile erection and yawning in male rats. Neurosci. Lett. (1994) 179(1-2):9-12.
118. MELIS MR, ARGIOLAS A: Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats. Brain Res. Bull. (1993) 32(1):71-74.
119. MELIS MR, ARGIOLAS A: Nitric oxide donors induce penile erection and yawning when injected in the central nervous system of male rats. Eur. J. Pharmacol. (1995) 294(1):1-9.
120. MELIS MR, ARGIOLAS A: Role of central nitric oxide in the control of penile erection and yawning. Prog. Neuropsychopharmacol. Biol. Psychiatry (1997) 21(6):899-922.
121. MELIS MR, SUCCU S, IANNUCCI U, ARGIOLAS A: Oxytocin increases nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats: correlation with penile erection and yawning. Regul. Pept. (1997) 69(2):105-111.
122. POGGIOLI R, BENELLI A, ARLETTI R, CAVAZZUTI E, BERTOLINI A: Nitric oxide is involved in the ACTH-induced behavioral syndrome. Peptides (1995) 16(7):1263-1268.
123. SATO Y, HORITA H, KUROHATA T, ADACHI H, TSUKAMOTO T: Effect of the nitric oxide level in the medial preoptic area on male copulatory behavior in rats. Am. J. Physiol. (1998) 274(1 Pt 2):R243-R247.
124. MELIS MR, SUCCU S, MAURI A, ARGIOLAS A. Nitric oxide production is increased in the paraventricular nucleus of the hypothalamus of male rats during non-contact penile erections and copulation. Eur. J. Neurosci. (1998) 10(6):1968-1974.
125. MIZUSAWA H, HEDLUND P, ANDERSSON KE: alpha-Melanocyte stimulating hormone and oxytocin induced penile erections, and intracavernous pressure increases in the rat. J. Urol. (2002) 167(2 Pt 1):757-760.
126. VEMULAPALLI R, KUROWSKI S, SALISBURY B, PARKER E, DAVIS H: Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO. Br. J. Pharmacol. (2001) 134(8):1705-1710.
127. TANG Y, RAMPIN O, GIULIANO F, UGOLINI G: Spinal and brain circuits to motoneurons of the bulbospongiosus muscle: retrograde transneuronal tracing with rabies virus. J. Comp. Neurol. (1999) 414(2):167-192.
128. MELIS MR, STANCAMPIANO R, FRATTA W, ARGIOLAS A: Oxytocin concentration changes in different rat brain areas but not in plasma during aging. Neurobiol. Aging (1992) 13(6):783-786.
129. ARGIOLAS A, MELIS MR, VARGIU L, GESSA GL: d(CH2)5Tyr(Me)-[Orn8]vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1-24). Eur. J. Pharmacol. (1987) 134(2):221-224.
130. MELIS MR, MAURI A, ARGIOLAS A: Apomorphine-and oxytocin-induced penile erection and yawning in intact and castrated male rats: effect of sexual steroids. Neuroendocrinology (1994) 59(4):349-354.
131. ARGIOLAS A, MELIS MR, MAURI A, GESSA GL: Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not by ACTH in rats. Brain Res. (1987) 421(1-2):349-352.
132. LIU YC, SALAMONE JD, SACHS BD: Impaired sexual response after lesions of the paraventricular nucleus of the hypothalamus in male rats. Behav. Neurosci. (1997) 111(6):1361-1367.
133. WITT DM, INSEL TR: Increased Fos expression in oxytocin neurons following masculine sexual behavior. J. Neuroendocrinol. (1994) 6(1):13-18.
134. CARMICHAEL MS, HUMBERT R, DIXEN J et al.: Plasma oxytocin increases in the human sexual response. J. Clin. Endocrinol. Metab. (1987) 64(1):27-31.
135. MURPHY MR, SECKL JR, BURTON S, CHECKLEY SA, LIGHTMAN SL: Changes in oxytocin and vasopressin secretion during sexual activity in men. J. Clin. Endocrinol. Metab. (1987) 65(4):738-741.
136. SRILATHA B, ADAIKAN PG: Oestrogen-androgen crosstalk in the pathophysiology of erectile dysfunction. Asian J. Androl. (2003) 5(4):307-313.
137. OETTEL M: Is there a role for estrogens in the maintenance of men's health? Aging Male (2002) 5(4):248-257.
138. COHEN PG: The role of estradiol in the maintenance of secondary hypogonadism in males in erectile dysfunction. Med. Hypotheses (1998) 50(4):331-333.
139. MANZO J, CRUZ MR, HERNANDEZ ME, PACHECO P, SACHS BD: Regulation of noncontact erection in rats by gonadal steroids. Horm. Behav. (1999) 35(3):264-270.
140. HEATON JP, VARRIN SJ: Effects of castration and exogenous testosterone supplementation in an animal model of penile erection. J. Urol. (1994) 151(3):797-800.
141. DAVIDSON JM: Activation of the male rat's sexual behavior by intracerebral implantation of androgen. Endocrinology (1966) 79(4):783-794.
142. LISK RD: Neural localization for androgen activation of copulatory behavior in the male rat. Endocrinology (1967) 80(4):754-761.
143. GRECO B, EDWARDS DA, ZUMPE D, CLANCY AN: Androgen receptor and mating-induced fos immunoreactivity are co-localized in limbic and midbrain neurons that project to the male rat medial preoptic area. Brain Res. (1998) 781(1-2):15-24.
144. ARGIOLAS A, MELIS MR, MURGIA S, SCHIOTH HB: ACTH- and alpha-MSH-induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors. Brain Res. Bull. (2000) 51(5):425-431.
145. WESSELLS H, FUCIARELLI K, HANSEN J et al.: Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J. Urol. (1998) 160(2):389-393.
146. WESSELLS H, LEVINE N, HADLEY ME, DORR R, HRUBY V: Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. Int. J. Impot. Res. (2000) 12(Suppl. 4):S74-S79.
147. WESSELLS H, GRALNEK D, DORR R et al.: Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology (2000) 56(4):641-646.
148. MOLINOFF PB, SHADIACK AM, EARLE D, DIAMOND LE, QUON CY: PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann. NY Acad. Sci. (2003) 994:96-102.
149. ROSARIA MELIS M, SPANO MS, SUCCU S, ARGIOLAS A: Activation of gamma-aminobutyric acid(A) receptors in the paraventricular nucleus of the hypothalamus reduces apomorphine, N-methyl-D-aspartic acid- and oxytocin-induced penile erection and yawning in male rats. Neurosci. Lett. (2000) 281(2-3):127-130.
150. MELIS MR, ARGIOLAS A: Reduction of drug-induced yawning and penile erection and of noncontact erections in male rats by the activation of GABAA receptors in the paraventricular nucleus: involvement of nitric oxide. Eur. J. Neurosci. (2002) 15(5):852-860.
151. MELIS MR, SUCCU S, SPANO MS, ARGIOLAS A: Morphine injected into the paraventricular nucleus of the hypothalamus prevents noncontact penile erections and impairs copulation: involvement of nitric oxide. Eur. J. Neurosci. (1999) 11(6):1857-1864.
152. SPECTOR IP, CAREY MP; Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch. Sex. Behav. (1990) 19(4):389-408.
153. SIMONS JS, CAREY MP: Prevalence of sexual dysfunctions: results from a decade of research. Arch. Sex. Behav. (2001) 30(2):177-219.